MAPK1 and lung adenocarcinoma: Interestingly, Venugopalan et al. demonstrated that SCAMP3 acts as a tumor suppressor in lung adenocarcinoma by modulating ERK, rather than what had been observed in other types of cancer, uncovering its dual role [11,14,22].